STERIS plc (NYSE:STE – Get Free Report)’s stock price traded up 4.1% during mid-day trading on Friday. The company traded as high as $263.14 and last traded at $263.7260. 109,130 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 769,788 shares. The stock had previously closed at $253.44.
Analysts Set New Price Targets
Several brokerages have recently issued reports on STE. Jefferies Financial Group raised STERIS from a “hold” rating to a “buy” rating and upped their price objective for the stock from $232.00 to $305.00 in a report on Friday. Weiss Ratings raised shares of STERIS from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, November 9th. Morgan Stanley raised shares of STERIS from an “overweight” rating to a “buy” rating in a report on Friday. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, UBS Group decreased their price target on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research note on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $283.50.
View Our Latest Research Report on STERIS
STERIS Stock Performance
STERIS (NYSE:STE – Get Free Report) last released its earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share for the quarter, beating the consensus estimate of $2.68 by $0.26. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.56 billion. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.47 EPS. Equities research analysts expect that STERIS plc will post 11.46 earnings per share for the current fiscal year.
STERIS Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be issued a $0.69 dividend. This represents a $2.76 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Tuesday, November 17th. STERIS’s dividend payout ratio (DPR) is 32.74%.
Insider Activity
In related news, Director Mohsen Sohi sold 4,893 shares of STERIS stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $253.22, for a total transaction of $1,239,005.46. Following the completion of the transaction, the director directly owned 24,305 shares of the company’s stock, valued at approximately $6,154,512.10. The trade was a 16.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Karen Burton sold 5,880 shares of the company’s stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total transaction of $1,503,045.60. Following the transaction, the chief financial officer owned 12,956 shares in the company, valued at $3,311,812.72. The trade was a 31.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.12% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the business. Deroy & Devereaux Private Investment Counsel Inc. increased its position in STERIS by 51.0% during the 3rd quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 25,355 shares of the medical equipment provider’s stock valued at $5,325,000 after purchasing an additional 8,560 shares during the period. Corient Private Wealth LP raised its holdings in shares of STERIS by 109.7% in the 2nd quarter. Corient Private Wealth LP now owns 20,978 shares of the medical equipment provider’s stock valued at $4,417,000 after purchasing an additional 10,976 shares in the last quarter. Copeland Capital Management LLC lifted its position in shares of STERIS by 13.7% in the 3rd quarter. Copeland Capital Management LLC now owns 177,778 shares of the medical equipment provider’s stock worth $37,335,000 after purchasing an additional 21,353 shares during the period. Perpetual Ltd lifted its position in shares of STERIS by 9.5% in the 3rd quarter. Perpetual Ltd now owns 69,157 shares of the medical equipment provider’s stock worth $14,524,000 after purchasing an additional 5,974 shares during the period. Finally, Squarepoint Ops LLC lifted its position in shares of STERIS by 1,373.7% in the 2nd quarter. Squarepoint Ops LLC now owns 41,898 shares of the medical equipment provider’s stock worth $8,822,000 after purchasing an additional 39,055 shares during the period. Institutional investors own 94.69% of the company’s stock.
STERIS Company Profile
STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.
Recommended Stories
- Five stocks we like better than STERIS
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
